As of February 2025 Aurobindo Pharma has a market cap of $7.52 Billion USD. This makes Aurobindo Pharma the world's 2118th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | $7.52 B | -12.83% |
2024 | $8.63 B | 13.1% |
2023 | $7.63 B | 146.04% |
2022 | $3.10 B | -46.31% |
2021 | $5.78 B | -21.68% |
2020 | $7.38 B | 96.64% |
2019 | $3.75 B | -38.88% |
2018 | $6.14 B | -2.38% |
2017 | $6.29 B | 9.13% |
2016 | $5.76 B | -25.1% |
2015 | $7.69 B | 47.38% |
2014 | $5.22 B | 182.08% |
2013 | $1.85 B | 83.86% |
2012 | $1.00 B | 115.31% |
2011 | $0.46 B | -71.38% |
2010 | $1.63 B | 54.65% |
2009 | $1.05 B | 460.91% |
2008 | $0.18 B | -74.48% |
2007 | $0.73 B | -13.57% |
2006 | $0.85 B | 84.18% |
2005 | $0.46 B |
On Feb 20th, 2025 the market cap of Aurobindo Pharma was reported to be: